Long-term efficacy of first-line versus second-line pegylated interferon in the treatment of essential thrombocythaemia and polycythaemia vera - results of a single-centre retrospective audit

被引：0
|
作者：
James, Daniel [1 ]
Verigou, Eleni-Anna [1 ]
Wilson, Andrew [2 ]
O'Nions, Jenny [2 ]
Ahmed, Syeda [2 ]
Alimam, Samah [3 ]
Sekhar, Mallika [2 ]
Lambert, Jonathan [2 ]
机构：
[1] UCL, Sch Med, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2021-PO
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [31] Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
    Lee, Dong Ho
    Lee, Jeong Min
    Lee, Jae Young
    Kim, Se Hyung
    Yoon, Jung Hwan
    Kim, Yoon Jun
    Han, Joon Koo
    Choi, Byung Ihn
    RADIOLOGY, 2014, 270 (03) : 900 - 909
  • [32] Extracorporeal photopheresis as early second-line treatment for patients with steroid-dependent or refractory acute graft-versus-host disease: a single-centre experience
    Sakellari, I.
    Batsis, I.
    Gavriilaki, E.
    Panteliadou, A-K
    Lazaridou, A.
    Leontopoulos, K.
    Mallouri, D.
    Bouinta, A.
    Constantinou, V.
    Yannaki, E.
    Smias, C.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S213 - S213
  • [33] The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: Long-term studies using the intratumoral aromatase postmenopausal breast cancer model
    Long, BJ
    Jelovac, D
    Thiantanawat, A
    Brodie, AM
    CLINICAL CANCER RESEARCH, 2002, 8 (07) : 2378 - 2388
  • [34] Second-line nintedanib plus docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: updated efficacy and safety results from VARGADO Cohort C
    Grohe, C.
    Wehler, T.
    Dechow, T.
    Henschke, S.
    Schuette, W.
    Dittrich, I
    Hammerschmidt, S.
    Mueller-Huesmann, H.
    Schumann, C.
    Krueger, S.
    Atz, J.
    Kaiser, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 110 - 110
  • [35] Second-line nintedanib plus docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C
    Grohe, C.
    Wehler, T.
    Dechow, T.
    Henschke, S.
    Schuette, W.
    Dittrich, I.
    Hammerschmidt, S.
    Mueller-Huesmann, H.
    Schumann, C.
    Krueger, S.
    Atz, J.
    Kaiser, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S1018 - S1019
  • [36] Long-Term Efficacy and Safety of Intense Immunosuppression as First-Line Therapy in Clinically Active Relapsing MS: A New Treatment Algorithm
    Perumal, Jai S.
    Hreha, Stephanie
    Caon, Christina
    Bao, Fen
    Penmesta, Ramya
    Zak, Imad
    Tselis, Alexandros
    Khan, Omar
    NEUROLOGY, 2009, 72 (11) : A360 - A360
  • [37] Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia
    Zhang, Yingmei
    Zhang, Zhuo
    Li, Jinmei
    Li, Limin
    Han, Xueying
    Han, Lina
    Hu, Longhu
    Wang, Shuye
    Zhao, Yanhong
    Li, Xiaoxia
    Zhang, Ying
    Fan, Shengjin
    Lv, Chengfang
    Li, Yinghua
    Su, Yanhua
    Zhao, Hui
    Zhang, Xin
    Zhou, Jin
    CANCER, 2013, 119 (01) : 115 - 125
  • [38] Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea
    Renso, Rossella
    Aroldi, Andrea
    Pioltelli, Pietro
    Gambacorti-Passerini, Carlo
    Elli, Elena Maria
    BLOOD CANCER JOURNAL, 2018, 8
  • [39] Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea
    Rossella Renso
    Andrea Aroldi
    Pietro Pioltelli
    Carlo Gambacorti-Passerini
    Elena Maria Elli
    Blood Cancer Journal, 8
  • [40] Gefitinib as the first-line treatment in metastatic adenocarcinoma patients with EGFR mutation-positive: A single-centre retrospective cohort study in Hospital Pulau Pinang, Malaysia
    Appava, Sumithra
    Subramaniam, Deepa Priya Naidu
    Muneswarao, Jaya
    Tan, Ai Lian
    Pereirasamy, Lalitha
    Goon, Ai Khiang
    Muthukumaru, Umadevi
    Ali, Irfhan Ali Hyder
    RESPIROLOGY, 2023, 28 : 318 - 319
12345